Mr. Speaker, in his great wisdom, my hon. colleague from Berthier—Maskinongé has put his finger on a fundamental problem.
I mentioned the Naylor report earlier, which indicated that Canada was not faring very well in terms of basic research. What we are learning from the pandemic is that health crises, which could happen more frequently because of global warming, will leave Canada exposed. This will often be the case, because Canada does not have the research ecosystem needed to develop its vaccine production capacity. Consequently, it will often be dependent on external supply. We need to recognize this right away. The alarm bells sounded during the SARS outbreak, and now COVID-19 is showing us that lockdown can be very costly and has a certain morbidity associated with it. It is therefore essential to reinvest in research.